3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
2
Lymphoid
2
Thoracic
1
Other hematologic neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Venous Thromboembolism
8
Venous Thrombosis
4
Neoplasms
4
Pulmonary Embolism
2
Lung Neoplasms
2
Vascular Diseases
1
Urogenital Neoplasms
1
Thrombosis
1
Thromboembolism
1
Thrombocytopenia
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
37
fludarabine phosphate
31
Busulfan
25
Antilymphocyte Serum
22
Mycophenolic Acid
20
Melphalan
19
Cyclosporine
19
Peripheral Blood Stem Cell Transplantation
16
Filgrastim
16
Cord Blood Stem Cell Transplantation
16
Whole-Body Irradiation
14
Tacrolimus
14
Radiotherapy
14
Methylprednisolone
13
fludarabine
11
Methotrexate
8
Epoetin Alfa
8
Etoposide
7
Cytarabine
7
Thiotepa
6
Alemtuzumab
6
thymoglobulin
4
Granulocyte Colony-Stimulating Factor
4
Darbepoetin alfa
3
Bone Marrow Transplantation
3
Stem Cell Transplantation
2
Sirolimus
2
Rituximab
2
Mesna
2
Influenza Vaccines
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma
×
Tinzaparin
×
Classical hematology
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled